05

March

2020

|

20:41

Asia/Singapore

Duke-NUS partners with Arcturus Therapeutics to develop COVID-19 vaccine

Duke-NUS and Arcturus Therapeutics, a leading messenger RNA medicines company, have announced their partnership to develop a COVID-19 vaccine for Singapore. The vaccine will take advantage of the unique platform developed at Duke-NUS which allows rapid screening of vaccines for effectiveness and safety https://www.duke-nus.edu.sg/about/media/media-releases/media-releases/arcturus-dukenus-covid-19-vaccine-using-starr-technology